Sumitomo Seika ChemicalsSumitomo Seika Chemicals Company,Limited.4008東証プライム化学FY ending Mar 2026, consolidated, J-GAAP
Out of every ¥100 of sales, about ¥10 is left as operating profit. Revenue changed +0.5% from the prior year, operating profit +35.0%.
Net margin × asset turnover = ROA; ROA × financial leverage = ROE
Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.
| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE |
|---|---|---|---|---|---|
| 2022 | 5.1% | 0.95× | 4.9% | 1.67× | 8.1% |
| 2023 | 6.0% | 1.15× | 6.9% | 1.64× | 11.3% |
| 2024 | 4.3% | 1.09× | 4.7% | 1.64× | 7.7% |
| 2025 | 4.0% | 1.06× | 4.3% | 1.68× | 7.2% |
| 2026 | 5.2% | 1.01× | 5.2% | 1.71× | 8.9% |
Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.
Annual trends in tangible-asset ratios and goodwill balance.
Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition
Track R&D investment and how long operating capital remains tied up before sales turn into cash.
R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 115,583 | 143,041 | 142,986 | 147,571 | 148,354 |
| Cost of revenue | 89,434 | 112,905 | 114,979 | 116,890 | 112,919 |
| Gross profit | 26,149 | 30,135 | 28,007 | 30,681 | 35,435 |
| SG&A | 18,076 | 19,680 | 18,477 | 19,968 | 20,970 |
| Operating income | 8,072 | 10,454 | 9,529 | 10,712 | 14,464 |
| Pretax income | 8,453 | 11,249 | 8,722 | 8,322 | 11,677 |
| Income tax | 2,499 | 2,624 | 2,555 | 2,361 | 4,000 |
| Net income attributable to owners | 5,895 | 8,592 | 6,166 | 5,961 | 7,677 |
| Operating margin | 7.0% | 7.3% | 6.7% | 7.3% | 9.7% |
Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.
Each bar totals 100% of assets; other is the residual.
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|
| Cash and equivalents | ¥29.2B | ¥23.6B | ¥20.9B | ¥16.1B | ¥18B |
| Total assets | ¥121.3B | ¥126.7B | ¥136.3B | ¥141.5B | ¥152.7B |
| Net assets | ¥81.9B | ¥86.7B | ¥95.1B | ¥94.3B | ¥103.6B |
| Share capital | ¥9.7B | ¥9.7B | ¥9.71B | ¥9.73B | ¥9.74B |
| Property, plant and equipment | ¥34.3B | ¥34.5B | ¥39.9B | ¥51.7B | ¥58.7B |
| Intangible assets excluding goodwill | ¥200M | ¥2.23B | ¥3.53B | ¥4.12B | ¥4.2B |
| Investment securities | ¥1.61B | ¥941M | ¥1.49B | ¥1.2B | ¥626M |
| Current assets | ¥81.3B | ¥85.2B | ¥87B | ¥80.1B | ¥82.4B |
| Current liabilities | ¥37.5B | ¥38.4B | ¥39.5B | ¥40.5B | ¥32.8B |
| Trade payables | ¥16.6B | ¥19.2B | ¥19.8B | ¥17.5B | ¥16.3B |
| Short-term borrowings | ¥11B | ¥12.2B | ¥11.2B | ¥13.3B | ¥2.98B |
| Long-term borrowings | — | — | — | ¥5B | ¥14.5B |
| Total liabilities | ¥39.4B | ¥40B | ¥41.3B | ¥47.2B | ¥49.1B |
| Non-controlling interests | ¥3.17B | — | — | — | — |
| Equity attributable to owners of parent | ¥72.5B | ¥79B | ¥81.5B | ¥83.8B | ¥87.9B |
| Retained earnings | ¥56.5B | ¥62.9B | ¥66.4B | ¥69.7B | ¥74.7B |
| Treasury stock | -¥1.21B | -¥1.21B | -¥2.21B | -¥3.2B | -¥4.2B |
EDINET (FSA Japan)
有価証券報告書－第113期(2025/04/01－2026/03/31)
EDINET (FSA Japan)
訂正有価証券報告書－第112期(2024/04/01－2025/03/31)
EDINET (FSA Japan)
有価証券報告書－第111期(2023/04/01－2024/03/31)
EDINET (FSA Japan)
有価証券報告書－第110期(2022/04/01－2023/03/31)
EDINET (FSA Japan)
有価証券報告書－第109期(令和3年4月1日－令和4年3月31日)
EDINET (FSA Japan)
有価証券報告書－第108期(令和2年4月1日－令和3年3月31日)
Extracted from XBRL: 51 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.